Top stocks | Open an Account  | Login | Demo
Sunday, August 03, 2008
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity  |  Derivatives  |  IPO  |  Commodity  |  Mutual Funds  |  Offshore  |  Insurance  |  Gold coins  |  PMS  |  Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Offshore News    News Ticker   


Mutual Fund News
Jul 25 2008 12:45PM
Birla Sun Life MF declares dividend
Birla Sun Life Mutual Fund has declared dividend under the dividend option of the Birla Sun Life Quarterly Interval Fund - Series 7. The fund house has fixed 28 July 2008 as the record date for the declaration of dividend.

The fund house has decided to distribute 100% of surplus available as on record date as dividend under the schemes. The NAV of Birla Sun Life Quarterly Interval Fund - Series 7 was Rs 10.2082 as on 22 July 2008.

Birla Sun Life Quarterly Interval Fund - Series 7 is an interval income scheme with an investment objective to generate regular income through investments in debt and money market instruments.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Technical charts
 
Customer Service
 
Branch Locator
 
Careers
 



SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in | Glossary | Site Map
Copyright© 2008. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]